Treating Schizophrenia

December, 2009 | Vol: 7 Issue: 12

In this issue

Learning Objective

Learning Objectives, Dec. 2009

This CME/CE activity is intended for psychiatrists, psychiatric nurses, psychologists and other health care professionals with an interest in the diagnosis and treatment of psychiatric disorders.


Saphris and Fanapt: Two New Antipsychotics

You've probably heard about Fanapt (iloperidone) and Saphris (asenapine), two antipsychotics that have recently won FDA approval for the acute treatment of schizophrenia, and, in the case of Saphris, for the treatment of manic and mixed episodes of bipolar disorder. Are these more “me too”...

“Risk Syndrome for First Psychosis”: A Valid Diagnosis in Psychiatry?

One of the most controversial topics for the DSM-V committee is whether to include a new diagnosis called Risk Syndrome for First Psychosis. Patients with schizophrenia commonly report a history of prodromal symptoms before developing the full-blown disorder...

Research Update

Expert QA